Delhi police dismantled a ₹25 crore syndicate manufacturing counterfeit cancer drugs like Keytruda. Criminals refilled genuine vials with dextrose or antifungals, selling them for lakhs. The racket, allegedly aided by hospital insiders, affected over 200 patients and caused at least one death. The case highlights how high costs and supply gaps fuel life-threatening pharmaceutical fraud.